🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Insmed Incorporated
ARIKAYCE, Brensocatib, Treprostinil Palmitil Inhalation Powder
Insmed Incorporated is a biopharmaceutical company founded in 1988, headquartered in Bridgewater, New Jersey. It develops and commercializes therapies for serious and rare diseases, including ARIKAYCE for Mycobacterium avium complex lung disease, Brensocatib for bronchiectasis and neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder for pulmonary arterial hypertension.
About | Leadership | Directors | About | Contact | Contact | Contact | Culture | Culture | Careers | Culture | Jobs | Culture | Culture | Culture | Jobs | Jobs | Jobs | Careers | About | About
Symbol: INSM
Recent Price: $68.87
Industry: Biotechnology
CEO: Mr. William H. Lewis J.D., M.B.A.
Sector: Healthcare
Employees: 912
Address: 700 US Highway 202/206, Bridgewater, NJ 08807
Phone: 908 977 9900
Leadership
- William H. Lewis, J.D., M.B.A., Chair and Chief Executive Officer
- David R. Brennan, Lead Independent Director
- Alfred F. Altomari, Director
- Elizabeth McKee Anderson, Director
- Clarissa Desjardins, Ph.D., Director
- Leo Lee, Director
- David W.J. McGirr, Director
- Carol A. Schafer, Director
- Melvin Sharoky, M.D., Director
Last updated: 2024-12-31